Cite
HARVARD Citation
Martits‐Chalangari, K. et al. (2022). ALVR109, an off‐the‐shelf partially HLA matched SARS‐CoV‐2–specific T cell therapy, to treat refractory severe COVID‐19 pneumonia in a heart transplant patient: Case report. American journal of transplantation. 22 (4), pp. 1261-1265. [Online].